Review
Open access
Aug 2026
Therapies for Cardiovascular-Kidney-Liver-Metabolic Syndrome: Reappraisal of Fibrates.
Cardiovascular disease, chronic kidney disease (CKD), type 2 diabetes mellitus (T2DM), obesity and metabolic dysfunction-associated steatohepatitis (MASH) frequently coexist and share overlapping pathophysiology, forming the proposed cardiovascular-kidney-liver-metabolic (CKLM) syndrome. Although contemporary therapies...
Virginia Anagnostopoulou, Christoforos K. Travlos, L. Marinho et al.
· Diabetes, obesity and metabo... · 0 citations